Are you Dr. Crawford?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-689-7210Fax+1 305-325-8387
Summary
- Dr. David Crawford, MD is a pediatric hematologist/oncologist in Miami, Florida. He is currently licensed to practice medicine in Florida, Oklahoma, and Alabama. He is affiliated with UMHC - Bascom Palmer Eye Institute.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 1996 - 1999- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1994 - 1996
University of Texas Southwestern Medical SchoolClass of 1994
Certifications & Licensure
FL State Medical License 2021 - 2025
OK State Medical License 2008 - 2021
AL State Medical License 2002 - 2008- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 11 citationsExperimental Cerebral Malaria Develops Independently of Endothelial Expression of Intercellular Adhesion Molecule-1 (ICAM-1)Theresa N. Ramos, Daniel C. Bullard, Meghan M. Darley, Kristin K. McDonald, David F. Crawford
The Journal of Biological Chemistry. 2013-04-19 - 15 citationsInactivation of the ubiquitin conjugating enzyme UBE2Q2 causes a prophase arrest and enhanced apoptosis in response to microtubule inhibiting agentsSami Banerjee, William S. Brooks, David F. Crawford
Oncogene. 2007-10-04 - 30 citationsG2E3 is a dual function ubiquitin ligase required for early embryonic development.William S. Brooks, E. Scott Helton, Sami Banerjee, Melanie Venable, Larry W. Johnson
The Journal of Biological Chemistry. 2008-08-08
Grant Support
- Transcriptional Control Of The G2dna Damage CheckpointNational Cancer Institute2002–2004
- Transcriptional Control Of The G2dna Damage CheckpointNational Cancer Institute2000–2001
